Leukemia is treatable, and many people go into remission or recover completely
Yes, leukemia is treatable. Doctors have multiple ways to fight it, and outcomes have improved significantly over the past two decades. Whether treatment works depends on the type of leukemia you have, your age, how advanced it is when found, and how your body responds to treatment. Some people achieve remission—meaning cancer cells become undetectable—and stay cancer-free for years or life. Others may need ongoing treatment to keep the disease controlled.
The goal of leukemia treatment is not always to cure it outright. For some types, especially in older adults, the goal may be to slow its growth, manage symptoms, and extend life while keeping side effects manageable. For others, particularly in children and younger adults, cure is often possible.
Key Takeaways
- Leukemia treatment options include chemotherapy, targeted drugs, immunotherapy, and stem cell transplants, often used in combination.
- Remission rates vary widely by leukemia type and age—acute leukemias in children have much higher remission rates than chronic leukemias in older adults.
- Your doctor will recommend a treatment plan based on your specific diagnosis, age, overall health, and how the leukemia cells behave in the lab.
- Treatment can cause significant side effects, and managing them is an important part of your care plan.
- Clinical trials may offer access to newer treatments not yet widely available.
How doctors treat leukemia
Chemotherapy is the most common first treatment. It uses drugs to kill cancer cells or stop them from dividing. Chemotherapy for leukemia is usually given through an IV (intravenous line) or sometimes as a pill. The drugs circulate through your bloodstream to reach leukemia cells throughout your body. Treatment typically happens in cycles—a period of treatment followed by a recovery period—and can last weeks to months depending on the type of leukemia.
Targeted therapy drugs attack specific features of leukemia cells. For example, some leukemias have a genetic change called the Philadelphia chromosome. Drugs like imatinib (Gleevec) target this specific change and have transformed treatment for chronic myeloid leukemia. Your doctor will test your leukemia cells to see if they have targetable mutations.
Immunotherapy helps your immune system recognize and destroy leukemia cells. CAR-T cell therapy is one type: doctors remove your immune cells, modify them in the lab to attack leukemia, and return them to your body. This approach has shown dramatic results in certain acute leukemias, especially in children and younger adults.
Stem cell transplant (also called bone marrow transplant) replaces diseased bone marrow with healthy cells from a donor or from your own cells collected and treated earlier. This is intensive treatment, usually reserved for people in remission or those whose leukemia has returned. It carries real risks but offers the possibility of a cure for some people.
Remission rates vary by leukemia type and age
Remission rates differ dramatically depending on what kind of leukemia you have. Acute lymphoblastic leukemia (ALL) in children has remission rates above 85 percent, with many children becoming long-term survivors. In adults over 50, the rate drops to around 40 to 50 percent, partly because older bodies tolerate intensive chemotherapy differently.
Acute myeloid leukemia (AML) in younger adults achieves remission in 60 to 70 percent of cases with standard treatment, though the rate is lower in older adults. Chronic myeloid leukemia (CML) has transformed dramatically since targeted drugs became available—most people now live for many years with the disease controlled by daily medication.
Chronic lymphocytic leukemia (CLL) progresses slowly in many people. Some never need treatment; others live for years with treatment. Newer drugs have extended survival significantly compared to chemotherapy alone.
These numbers represent averages. Your individual outcome depends on factors specific to you: your age, fitness level, whether your leukemia has certain genetic markers, and how well you tolerate treatment. Your doctor can discuss what the research shows for your particular situation.
What happens during and after treatment
During chemotherapy or other intensive treatment, you will have frequent blood tests and bone marrow biopsies to see how the leukemia is responding. You may spend time in the hospital, especially early in treatment, because chemotherapy weakens your immune system and you become vulnerable to infection. Your medical team will monitor you closely and treat infections aggressively.
Side effects are common and can be serious. Chemotherapy can cause nausea, vomiting, hair loss, fatigue, and low blood counts (which increases infection risk and bleeding risk). Targeted drugs and immunotherapy have different side effect profiles. CAR-T therapy can cause a severe inflammatory reaction called cytokine release syndrome. Your doctor will discuss what to expect and how to manage side effects.
If you achieve remission, you will continue regular follow-up visits and blood tests to watch for signs of relapse. The frequency of visits decreases over time if you remain in remission. Some people need maintenance therapy—lower-dose treatment given over months or years to keep the leukemia from returning. Others can stop treatment and be monitored without active therapy.
Factors that affect treatment success
Your age matters significantly. Younger people generally tolerate intensive treatment better and have higher remission rates. However, age alone does not determine outcome—some older adults do very well with treatment.
The leukemia's genetic makeup is crucial. Doctors test your leukemia cells for specific mutations and chromosomal changes. Some changes predict good response to treatment; others predict poor response. This information helps your doctor choose the most effective drugs for your particular leukemia.
How quickly the leukemia responds to initial treatment is a strong predictor. If your white blood cell count drops significantly after the first round of chemotherapy, that is a good sign. If it does not respond, your doctor may switch to a different approach.
Your overall health matters too. If you have other serious medical conditions, you may not be able to tolerate the most intensive treatments. Your doctor will balance the potential benefit of aggressive treatment against the risk it poses to you specifically.
Clinical trials and newer treatments
Leukemia treatment is an active area of research. Clinical trials test new drugs, new combinations of existing drugs, and new approaches like gene therapy. If standard treatment has not worked or if you want to explore newer options, ask your doctor whether any trials might be appropriate for you.
Trials are conducted at major cancer centers and some community hospitals. You can search for trials at ClinicalTrials.gov, a database maintained by the National Institutes of Health. Your oncologist can also help identify trials that match your diagnosis and situation.
Frequently Asked Questions
Can leukemia come back after remission?
Yes, relapse is possible, though the risk varies by leukemia type and how long you have been in remission. Some people relapse months after treatment ends; others remain in remission for decades. If relapse occurs, treatment options exist, though outcomes may differ from the first treatment.
What is the difference between remission and cure?
Remission means leukemia cells are no longer detectable in blood or bone marrow tests. Cure means the leukemia will never return. Doctors use remission because they cannot always predict whether leukemia will stay gone. Some people in remission for many years are considered functionally cured, but doctors remain cautious with the word.
Are there leukemias that cannot be treated?
All leukemias can be treated, though treatment goals differ. For some aggressive leukemias in very elderly or frail patients, the goal may be comfort and symptom management rather than remission. Your doctor will discuss realistic goals based on your specific situation.
How long does leukemia treatment take?
It varies widely. Intensive chemotherapy for acute leukemia may last several months of active treatment, followed by months or years of maintenance therapy or monitoring. Chronic leukemias treated with targeted drugs may require daily medication indefinitely. Your doctor will outline the expected timeline for your type of leukemia.
Can I work during leukemia treatment?
Many people continue working during treatment, though the intensity of your job and your treatment schedule matter. Some need to reduce hours or take leave during intensive phases. Talk with your employer about accommodations and with your medical team about what your energy level will likely be.